FGFR2 Gene Fusion/Rearrangement research hub

A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

This study is looking into a new medication called lirafugratinib for adults with certain types of advanced solid cancers where previous treatments haven't worked. It focuses on cancers with a specific gene change called FGFR2 fusion or rearrangement.